1437-Tergaflor ML

Page:4120
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as amended by Commission Regulation (EU) 2015/830
SAFETY DATA SHEET

TERGAFLOR ML
SECTION 1: Identification of the substance/mixture and of the

comoany/undertakin!!
• 1.1 Product identifier
Product name
Index number
EC number
CASnumber
TERGAFLOR ML
Not available.
Not available.
166736-08-9
Product description Degreaser

Product type liquid
Other means of identification Oxirane, 2-methyl-, polymer with oxiranc, mono(2-propylhcptyl)
ether
Chemical formula Cl0H22O.(C3H6O.C2H4O)x
1.2 Relevant identified uses of the substance or mixture and uses advised against
Identified uses
Product for treatment ofleather and other flexible material.
• 1.3 Details of the supplier of the safety data sheet
Tecnoderma S.r.l.
SEDE OPERATIV A: VIA CIOPPO SAN VITO
83029 SOLOFRA (AV)
ITALY
Telephone:+390825581667 Email: tecnoderma@tecnoderma.com
1.4 Emergency telephone number
National advisory body/Poison Center
Telephone number Not available.
Supplier
Telephone number
Not available.
Hours of operation
Not available.
Information limitations
Not available.
Version: 1.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, 1r ITTJTil [O)lO)[ElR lnn11R1
as
amended by Commission Regulation (EU) 2015/830
TERGAFLOR ML Page:5120
I SECTION 2: Hazards identification

2.1 Classification of the substance or mixture
Product definition Mono-constituent substance
Classification according to Regulation (EC) No. 1272/2008 ICLP/GHSI

Acute Tox. 4, H302
Eye Dam. l,H318
See Section 16 for the full text of the H statements declared above.
See Section 11 for more detailed information on health effects and symptoms.
• 2.2 Label elements
llazard pictograms
Signal word Danger

Hazard statements Harmful if swallowed.
Causes serious eye damage.
Precautionary statements
General Not applicable.

Prevention Wear eye or face protection. Do not eat, drink or smoke when using
this product. Wash hands thoroughly after handling.
Response IF SWALLOWED: Call a POISON CENTER or physician if you
feel unwell. IF IN EYES: Immediately call a POISON CENTER or
physician.
•
Storage Not applicable.
Disposal Dispose of contents and container in accordance with all local,
regional, national and international regulations.
Hazardous ingredients Oxirane, 2-methyl-, polymer with oxirane, mono(2-propylhcptyl)

ether
Supplemental label elements

Not applicable.
Annex XVII - Restrictions on the
Not applicable.
manufacture, placing on the
market and use of certain
dangerous substances, mixtures
and articles
Special packaging requirements

Containers to be fitted with
Not applicable.
child-resistant fastenings
Tactile warning of danger
Not applicable.
Version: /.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as
lf [flJTil fD)lO)lElR lnnllRI
Page:6/20
TERGAFLOR ML
2.3 Other hazards
Substance meets the criteria for No.

PDT according to Regulation
(EC) No. 1907/2006, Annex XIII
Substance meets the criteria for

Not available.
vPvB according to Regulation
•
(EC) No. 1907/2006, Annex XIII
Other hazards which do not

result in classification None known.
I SECTION 3: Composition/information on ingredients

3.1 Substances Mono-constituent substance
Classification Type
Product/ingredient name % Regulation (EC) No. 1272/2008 (CLP]

ldtntifitr-s
.
Oxirane, 2-mcthyl-, polymer CAS: 166736- Acute Tox. 4, H302 [A]
with oxirane, mono(2- 08-9 Eye Dam. I, H318
oronvlheotvll ether
[A] Constituent
[BJ Impurity
[CJ Stabilizing additive
See Section 16 for the full text of the H statements declared above.
There arc no additional ingredients present which, within the current knowledge of the supplier, are classified
and contribute to the classification of the substance and hence require reporting in this section.
Occupational exposure limits, if available, are listed in Section 8.
I SECTION 4: First aid measures

4.I Description of first aid measures
Eye contact Get medical attention immediately. Call a poison center or physician.
Immediately flush eyes with plenty of water, occasionally lifting the

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II,
1r fQ!Jnl r□]IO)[El lnnllRI
as
Page:7/20
TERGAFLOR ML
upper and lower eyelids. Check for and remove any contact lenses.
Continue to rinse for at least 10 minutes. Chemical burns must be
treated promptly by a physician.
Inhalation Get medical attention immediately. Call a poison center or physician.
Remove victim to fresh air and keep at rest in a position comfortable
for breathing. If it is suspected that fumes are still present, the rescuer
should wear an appropriate mask or self-contained breathing
apparatus. If not breathing, if breathing is irregular or if respiratory
arrest occurs, provide artificial respiration or oxygen by trained
personnel. It may be dangerous to the person providing aid to give
•
mouth-to-mouth resuscitation. If unconscious, place in recovery
position and get medical attention immediately. Maintain an open
airway. Loosen tight clothing such as a collar, tie, belt or waistband.
Get medical attention immediately. Call a poison center or physician.
Flush contaminated skin with plenty of water. Remove contaminated
Skin contact clothing and shoes. Wash contaminated clothing thoroughly with
water before removing it, or wear gloves. Continue to rinse for at
least IO minutes. Chemical bums must be treated promptly by a
physician. Wash clothing before reuse. Clean shoes thoroughly
before reuse.
Ingestion Get medical attention immediately. Call a poison center or physician.
Wash out mouth with water. Remove dentures if any. Remove victim
to fresh air and keep at rest in a position comfortable for breathing. If
material has been swallowed and the exposed person is conscious,
give small quantities of water to drink. Stop if the exposed person
feels sick as vomiting may be dangerous. Do not induce vomiting
unless directed to do so by medical personnel. If vomiting occurs, the
head should be kept low so that vomit does not enter the lungs.
Chemical bums must be treated promptly by a physician. Never give
anything by mouth to an unconscious person. If unconscious, place in
recovery position and get medical attention immediately. Maintain an
open airway. Loosen tight clothing such as a collar, tic, belt or
•
waistband.
No action shall be taken involving any personal risk or without
suitable training. If it is suspected that fumes are still present, the
rescuer should wear an appropriate mask or self-contained breathing
Protection of first-aiders apparatus. It may be dangerous to the person providing aid to give
mouth-to-mouth resuscitation. Wash contaminated clothing
thoroughly with water before removing it, or wear gloves.
4.2 Most important symptoms and effects, both acute and delayed
Potential acute health effects
Eye contact
Inhalation
May give off gas, vapor or dust that is very irritating or corrosive to
the respiratory system.
Skin contact
No known significant effects or critical hazards.
Ingestion
Harmful if swallowed.
Over-exposure signs/symptoms
Eye contact Adverse symptoms may include the following:

---
lflE[:U111[)J[]lEl IITnllRl
Conforms to Regulation (EC) No..1907/2006 (REACH). Annex II. as
Page:8120
TERGAFLOR ML
pain
watering
redness
No specific data.
Inhalation
Adverse symptoms may include the following:
Skin contact pain or irritation
redness
blistering may occur
•
stomach pains
Ingestion
4.J Indication of any immediate medical attention and special treatment needed
Treat symptomatically. Contact poison tre tmcnt spcc_ialist
Notes to physician immediately if large quantities have been mgestcd or mhaled.
Specific treatments No specific treatment.
I SECTION 5: Firefighting measures

5.I Extinguishing media
Suitable extinguishing media Use an extinguishing agent suitable for the surrounding fire.
Unsuitable extinguishing media None known.
5.2 Special hazards arising from the substance or mixture
•
Hazards from the substance In a fire or if heated, a pressure increase will occur and the container
or mixture may burst.
Hazardous thermal Decomposition products may include the following materials:
decomposition products carbon dioxide
carbon monoxide
5.3 Advice for firefighters
Special protective actions for Promptly isolate the scene by removing all persons from the vicinity
fire-fighters of the incident if there is a fire. No action shall be taken involving
any personal risk or without suitable training.
Special protective equipment for Fire-fighters should wear appropriate protective equipment and self
fire-fighters contained breathing apparatus (SCBA) with a full face-piece
operated in positive pressure mode. Clothing for fire-fighters
(including helmets, protective boots and gloves) conforming to
European standard EN 469 will provide a basic level of protection for
chemical incidents.
Additional information
Not applicable.
I SECTION 6: Accidental release measures

Version: 1.0 Date of issue/Date of revision: 29.nJ.2019 Date of previous issue:
Confonns to Regulation (EC) No. 1907/2006 (REACII). Annex II, as
lf Tll[]]lOJlE1 1nnllRl
6.1 Personal precautions, protective equipment and emergency procedures
For non-emergency personnel

o action shall be taken involving any personal risk or without
suitable training. Evacuate surrounding areas. Keep unnecessary and
unprotected personnel from entering. Do not touch or walk through
spilled material. Do not breathe vapor or mist. Provide adequate
ventilation. Wear appropriate respirator when ventilation is
inadequate. Put on appropriate personal protective equipment.
For emergency responders If specialized clothing is required to deal with the spillage, take note
of any information in Section 8 on suitable and unsuitable materials.
Sec also the information in "For non-emergency personnel".
6.2 Environmental precautions

Avoid dispersal of spilled material and runoff and contact with soil,
waterways, drains and sewers. Inform the relevant authorities if the
product has caused environmental pollution (sewers, waterways, soil
or air).
6.3 Methods and materials for containment and cleaning up
Small spill
Stop leak if without risk. Move containers from spill area. Dilute
with water and mop up if water-soluble. Alternatively, or ifwater
insoluble. absorb with an inert dry material and place in an
appropriate waste disposal container. Dispose of via a licensed waste
disposal contractor.
Large spill
Stop leak if without risk. Move containers from spill area. Approach
release from upwind. Prevent entry into sewers, water courses,
basements or confined areas. Wash spillages into an effluent
treatment plant or proceed as follows. Contain and collect spillage
with non-combustible, absorbent material e.g. sand, earth,
vermiculite or diatomaceous earth and place in container for disposal
according to local regulations. Dispose of via a licensed waste
disposal contractor. Contaminated absorbent material may pose the
same hazard as the spilled product.
6.4 Reference to other sections See Section 1 for emergency contact information.
Sec Section 8 for information on appropriate personal protective
equipment.
See Section 13 for additional waste treatment information.
SECTION 7: Handling and storage

7.1 Precautions for safe handling
Protective measures
Put on appropriate personal protective equipment (see Section 8). Do
not get in eyes or on skin or clothing. Do not breathe vapor or mist.
Do not ingest. If during normal use the material presents a
respiratory hazard, use only with adequate ventilation or wear
appropriate respirator. Keep in the original container or an approved
alternative made from a compatible material, kept tightly closed
when not in use. Empty containers retain product residue and can be
hazardous. Do not reuse container.
Advice on general occupational Eating, drinking and smoking should be prohibited in areas where
Versio11: 1.0 Dme ofissue/Dnte ofrevisio11: 2901.2019 Dme ofprevio11s issue:

as
lf {[!Jnl fO)lOllElR lnnllRI
TERGAFLOR ML Page:/0/20
hygiene
this material is handled, stored and processed. Workers should wash
hands and face before eating, drinking and smoking. Remove
contaminated clothing and protective equipment before entering
eating areas. See also Section 8 for additional infonnation on
hygiene measures.
7.2 Conditions for safe storage,
Store in accordance with local regulations. Store in original
including any incompatibilities
container protected from direct sunlight in a dry, cool and well
ventilated area, away from incompatible materials (see Section 10)
and food and drink. Store locked up. Keep container tightly closed
•
and sealed until ready for use. Containers that have been opened
must be carefully rescaled and kept upright to prevent leakage. Do
not store in unlabeled containers. Use appropriate containment to
avoid environmental contamination.
Keep from freezing. Stir before use.
73 Specific end use(s)
Recommendations
Not available.
Industrial sector specific
Not available.
solutions
\ SECTION 8: Exposure controls/personal protection

8.1 Control parameters
Occupational exposure limits
No exposure limit value known.

Recommended monitoring
•
If this product contains ingredients with exposure limits, personal,
workplace atmosphere or biological monitoring may be required to
determine the effectiveness of the ventilation or other control
measures and/or the necessity to use respiratory protective
equipment. Reference should be made to monitoring standards, such
procedures as the following: European Standard EN 689 (Workplace
atmospheres - Guidance for the assessment of exposure by
inhalation to chemical agents for comparison with limit values and
measurement strategy) European Standard EN 14042 (Workplace
atmospheres - Guide for the application and use of procedures for
the assessment of exposure to chemical and biological agents)
European Standard EN 482 (Workplace atmospheres - General
requirements for the performance of procedures for the
measurement of chemical agents) Reference to national guidance
documents for methods for the determination of hazardous
substances will also be required.
DNELs/DMELs
No DNELs/DMELs available.
PNECs
No PNECs available.
Version: 1.0 Date of issue/Date of revision: 29.01.2019 Date of previous
issue:
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex 11,
as
□
lf [TI1n1 fDll l§lR lnnllRI
Page:11120
TERGAFLOR ML
8.2 Exposure controls
Appropriate engineering controls

If user operations generate dust, fumes, gas, vapor or mist, use
process enclosures, local exhaust ventilation or other engineering
controls to keep worker exposure to airborne contaminants below
any recommended or statutory limits.
Individual protection measures
•
Wash hands, forearms and face thoroughly after handling chemical
products, before eating, smoking and using the lavatory and at the
end of the working period. Appropriate techniques should be used to
remove potentially contaminated clothing. Wash contaminated
Hygiene measures clothing before reusing. Ensure that eyewash stations and safety
showers are close to the workstation location.
Eye/face protection
Safety eyewear complying with an approved standard should be
used when a risk assessment indicates this is necessary to avoid
exposure to liquid splashes, mists, gases or dusts. If contact is
possible, the following protection should be worn, unless the
assessment indicates a higher degree of protection: chemical splash
goggles and/or face shield. If inhalation hazards exist, a full-face
respirator may be required instead.
Skin protection
Hand protection
Chemical-resistant, impervious gloves complying with an approved
standard should be worn at all times when handling chemical
products ifa risk assessment indicates this is necessary. Considering
the parameters specified by the glove manufacturer, check during
•
use that the gloves are still retaining their protective properties. It
should be noted that the time to breakthrough for any glove material
may be different for different glove manufacturers. In the case of
mixtures, consisting of several substances, the protection time of the
Body protection gloves cannot be accurately estimated.
Personal protective equipment- for the body should be selected based
on the task being performed and the risks involved and should be
approved by a specialist before handling this product.
Other skin protection Appropriate footwear and any additional skin protection measures
should be selected based on the task being performed and the risks
involved and should be approved by a specialist before handling this
product.
Respiratory protection Use a properly fitted, air-purifying or air-fed respirator complying
with an approved standard if a risk assessment indicates this is
necessary. Respirator selection must be based on known or
anticipated exposure levels, the hazards of the product and the safe
working limits of the selected respirator.
Environmental exposure controls Emissions from ventilation or work process equipment should be
checked to ensure they comply with the requirements of
environmental protection legislation. In some
cases, fume scrubbers, filters or engineering
modifications to the process equipment will be
necessary to reduce emissions to acceptable
levels.

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as lf[E[Ol1n1ro11alE1R 1nnllRl
TERGAFLOR ML Page: 12120
I SECTION 9: Physical and chemical properties

9.1 Information on basic physical and chemical properties
Appearance
Physical state
liquid
Color
Colorless. to Ycllowish.
•
Odor
Characteristic.
Odor threshold
Not available.
pH
7 [Cone. (% w/w): 50 g/1] @ 23 °C (DIN EN 1262)
Melting point/freezing point

10 °C
Initial boiling point and boiling

Not applicable.
range
Flash point
> 100 °C
Fire point
Not available.
Evaporation rate
Not available.
Flammability (solid, gas)
Non-flammable.
Upper/lower flammability or
Lower: Not available.
explosive limits
Upper: Not available.
Vapor pressure
•
Not available.
Vapor density
Not available.
Relative density
1 @20 °C
Solubility(ies)
Soluble in the following materials:
water
(15°C)
Partition coefficient: n
Not available.
octanol/water
Auto-ignition temperature
> 200 °c (DIN 51794)
Decomposition temperature
Not available.
Viscosity
Dynamic: 60 mPa.s @ 23 °C
Kinematic: 60 mm2/s @23 °C (DIN 51562)
Explosive properties
Not applicable.
Oxidizing properties
Not available.

Conforms to Regulation (EC) No. 1907/2006 (REACH) Annex II
as
amended by Commission Regulation (EU) 2015/830 ' '
1r ni
rDJlOJlElR1nn11R1
TERGAFLOR ML
Page:13120
voe (2004/42/EC) 0,2% w/w

Definition
at according to EU Directive 2004/42/EC: all organic compounds witha boilingpoint of<= 250
101.3 kPa oc
VOC (2010/75/EU) O % w/w
Definition according to EU Directive 2010/75/EU: all organic compounds witha vapour pressure of=>
0.01 kPa at 293,IS K
•
9.2 Other information
No additional information.
I SECTION 10: Stability and reactivity

I 0. I
Reactivity Not considered to be reactive according to our database.
The product is stable.

10.2 Chemical stability
Under normal conditions of storage and use, hazardous reactions
10.3 Possibility of hazardous will not occur.
reactions
No specific data.
10.4 Conditions to avoid
No incompatible product according to our database.
10.5 Incompatible materials
10.6
Under normal conditions of storage and use, hazardous
decomposition products should not be produced.
Hazardous decomposition
products
SECTION 11: Toxicolo ical information

11.1 Information on toxicological effects
• Product/ingredient name
TERGAFLOR ML
Acute toxicity
I
I Result
LD50 Oral I
I Species
Rat I
I Dose
50_0 2.000
mg/kg
I Exposure
I-
Conclusion/Summary Not available.
Acute toxicity estimates I Oral
Route
ATE value
571,4 mg/kg
Irritation/Corrosion
Conclusion/Summary
Skin
Not available.
Eyes
Not available.

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II as
amended by Commission Regulation (EU) 2015/830 '
1r ITTffll lO]lO] R lnn11R1
TERGAFLOR ML
Page: l-1120
Respiratory
Not available.
Sensitization
Conclusion/Summary
Skin
Not available.
Respiratory Not available.
Mutagenicity
Conclusion/Summary
•
Not available.
Carcinogenicity
Reproductive toxicity
Teratogenicity
Specific target organ toxicity (single exposure)

Not available.
Specific target organ toxicity (repeated exposure)

Not available.
Aspiration hazard
•
Not available.
Information on likely routes of

exposure Not available.
Potential acute health effects
Eye contact
Inhalation
May give off gas, vapor or dust that is very irritating or corrosive to
Skin contact the respiratory system.
Ingestion No known significant effects or critical hazards.
Harmful if swallowed.
Symptoms related to the physical, chemical and toxicological characteristics
Eye contact
pain
watering
redness
Inhalation
No specific data.
Skin contact
pain or irritation

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II. as
1r r ITrTrn1□tE1 1nn11R1
redness
blistering may occur
Ingestion
stomach pains
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Short term exposure
Potential immediate effects

Not available.
Potential delayed effects
•
Not available.
Long term exposure
Potential immediate effects

Not available.
Potential delayed effects
Not available.
Potential chronic health effects
Conclusion/Summary
Not available.
General
Carcinogenicity
Mutagenicity
Teratogenicity
Developmental effects
Fertility effects
I SECTION 12: Ecological information
• Product/ingredient name
TERGAFLOR ML
12.1 Toxicity
I Result
7 Acute EC50 I - IO mg/I

·1 Acute EC50 10 - 100 mg/I
I Species
I Water flea
7 Algae
I
I
I
Exposure
48 h
72 h
12.2 Persistence and degradability

Product/ingredient name Test Result Dose Inoculum
TERGAFLOR ML 303A Simulation - mg/I -
Test - Aerobic
Sewage
Treatment -
Activated Sludge
Units
Remarks: Bismuth-active substance Read-across

301B Ready - mg/I -

as
□
1r ]Jl lElR 1nnllRl
Page: 16120
TERGAFLOR ML
Biodegradability
- CO2 Evolution
Test
Conclusion/Summary Readily biodegradable
12.3 Bioaccumulative potential

Not available.
12.4 Mobility in soil
•
Soil/water partition coefficient Not available.
(KOC)
Mobility Not available.
12.5 Results of PBT and vPvB assessment
PBT
P: Not available.
B: Not available.
T:No.
vPvB vP: Not available.

vB: Not available.
12.6 Other adverse effects No known significant effects or critical hazards.
I SECTION 13: Disposal considerations

13.1 Waste treatment
•
methods
Product
The generation of waste should be avoided or minimized wherever
Methods of disposal
possible. Disposal of this product, solutions and any by-products
should at all times comply with the requirements of environmental
protection and waste disposal legislation and any regional local
authority requirements. Dispose of surplus and non-recyclable
products via a licensed waste disposal contractor. Waste should not
be disposed of untreated to the sewer unless fully compliant with the
requirements of all authorities with jurisdiction.
The classification of the product may meet the criteria for a
Hazardous waste hazardous waste.
Packaging
Methods of disposal
The generation of waste should be avoided or minimized wherever
possible. Waste packaging should be recycled. Incineration or
landfill should only be considered when recycling is not feasible.

Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II. as
TERGAFLOR ML Page:/7/20
Special precautions
This material and its container must be disposed of in a safe way.
Care should be taken when handling emptied containers that have
not been cleaned or rinsed out. Empty containers or liners may retain
some product residues. Avoid dispersal of spilled material and
runoff and contact with soil, waterways, drains and sewers.
SECTION 14: Transport information

ADR/RID ADN IMDG IATA
•
14.I UN number - - - -
14.2 UN proper Not regulated. Not regulated. Not regulated. Not regulated.
shipping name
14.3 Transport - - - -
hazard class(es)
14.4 Packing - - - -
group
14.5. No. No. No. No.
Environmental
hazards
Additional S(! cial (!rovisions: - - -
information Tunnel code: -
J 4.6 Special precautions for user Transport within user's premises: always transport in closed
containers that arc upright and secure. Ensure that persons
transporting the product know what to do in the event of an accident
or spillage.
•
14.7 Transport in bulk according to Annex II of MARPOL and the IBC Code
Not available.
I SECTION 15: Regulatory information

)5.J Safety, health and environmental regulations/legislation specific for the substance or mixture
EU Regulation (EC) No. 1907/2006 (REACH)

Annex XIV - Ust of substances subiect to authorization
Annex XIV: None of the components are listed.
Substances of very high concern: None of the components are listed.
Annex XVII - Restrictions on

Not applicable.
the manufacture, placing on the
market and use of certain
dangerous substances, mixtures
and articles
Version: /_(} Dale of issue/Dale of revision: 29.()/.2019 Date ofprrvious issue:

·Q ijlDJ@ijlmB
Conforms to Regulation (EC) No. 1907/2006 (REACH), Annex II, as
lffEMJDl[l]lEl lrtn
Page:18120
TERGAFLOR ML
Other EU regulations
Ozone depleting substances (I 005/2009/EU)

None of the components are listed.
Prior Informed Consent (PIC} (649/2012/EU)

Seveso Directive
This product is not controlled under the Seveso Directive.
•
National regulations
D.Lgs. I 52/06 Not classified.
International regulations
Chemical Weapon Convention List Schedules I. II & Ill Chemicals
Chemical Weapons Convention List Schedule I Chemicals

Chemical Weapons Convention List Schedule II Chemicals

None of the components arc listed.
Chemical Weapons Convention List Schedule Ill Chemicals

Montreal Protocol (Annexes A, B. C, El

• Stockholm Convention on Persistent Organic Pollutants

Annex A - Elimination - Production
Annex A - Elimination - Use

Annex B - Restriction - Production

Annex B - Restriction - Use

Annex C - Unintentional - Production

Rotterdam Convention on Prior Inform Consent (PIC)

UNECE Aarhus Protocol on POPs and Heavy Metals
Version: /.0 Date ofissue/DaJe of revision: 29.01.2019 Date of previous issue:

ir mmIDl\E\ 1nrnH1
-
CH) Annex ll,
as
. C No. 1907/2006 (REA '
Conforms to Regulat1@ (ER) lation (EU) 2015/830 Page: /9/20
amended by Comm1ss1on egu
TERGAFLOR ML
Heavy metals - Annex 1 .

POPs - Annex 1 - Production

POPs - Annex I - Use

POPs - Annex 2
•
POPs - Annex 3
None of the components are listed .
Inventory list
Australia Not determined.
Canada All components are listed or
China exempted. All components arc listed
Europe or exempted. All components arc listed
Japan or exempted. Not determined.
United States United States inventory (TSCA Sb): All components are listed or
exempted.
15.2 Chemical Safety Assessment This product contains substances for which Chemical Safety
Assessments are still required.
•
SECTION 16: Other information
Abbreviations and acronyms ATE Acute Toxicity Estimate
CLP Classification, Labelling and Packaging Regulation
[Regulation (EC) No. 1272/2008]
DMEL Derived Minimal Effect Level
DNEL Derived No Effect Level
EUH statement CLP-specific Hazard statement
PBT = Persistent, Bioaccumulativc and Toxic
PNEC = Predicted No Effect Concentration
RRN REACH Registration Number
vPvB = Very Persistent and Very Bioaccumulative
Procedure used to derive the classification according to Regulation /EC] No. 1272/2008 (CLP/GIISJ
Classification Justification
Acute Tox. 4, H302 On basis oftest data
Eye Dam. l,H318 Calculation method
Full text of abbreviated H statements
Version: 1.0 Drue of issue/Date of revision: 19.01.2019 Date of previous issue:

Version: 1.0 Drue of issue/Date of revision: 19.01.2019 Date of previous issue:
Conforms to Regulation (EC) No. 1907/2006 (REACH). Annex II.
as
1r rHn□lElR
lnnllRI
Page:2() 20
TERGAFLOR ML
11302 Harmful if swallowed.

11318 Causes serious eye damage.
Full text of classifications !CLP/GIIS)
Acute Tox. 4, 11302 ACUTE TOXICITY (oral) - Category 4

Eye Dam. 1, 11318 SERIOUS EYE DAMAGE/ EYE IRRITATIO - Category I
Date of issue/ Date of

29.01.2019
revision Date of previous
issue Version
1.0
Items where changes have been made to the previous version are highlighted in the body of this document by
two vertical lines.
oticc to reader
To the best of our knowledge, the information contained herein is accurate. llowever, neither the above
named supplier, nor any of its subsidiaries, assumes any liability whatsoever for the accuracy or
completeness of the information contained herein. Final determination of suitability of any material is
the sole responsibility of the user. All materials may pre cot unknown hazards and should be used with
caution. Although certain hazards arc described herein, we cannot guarantee that these arc the only
hazards that exist.
Annex to the extended Safety Data Sheet (eSDS)

Identification of the substance or mixture
Product definition Mono-constituent substance
Product name TERGAFLOR ML
Versio11: /.0 Date ofiss11e/Date of revisio11: 29.01.2019 Date ofpre,·io11s issue:

1437-Tergaflor ML

Uploaded by

Document Information

Copyright

Available Formats

Share this document

Share or Embed Document

Sharing Options

Did you find this document useful?

Is this content inappropriate?

Copyright:

Available Formats

1437-Tergaflor ML

Uploaded by

Copyright:

Available Formats

Page:4120

SAFETY DATA SHEET

SECTION 1: Identification of the substance/mixture and of the

• 1.1 Product identifier

Product description Degreaser

• 1.3 Details of the supplier of the safety data sheet

1.4 Emergency telephone number

National advisory body/Poison Center

Telephone number Not available.

Version: 1.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

I SECTION 2: Hazards identification

Product definition Mono-constituent substance

Classification according to Regulation (EC) No. 1272/2008 ICLP/GHSI

• 2.2 Label elements

Signal word Danger

General Not applicable.

Hazardous ingredients Oxirane, 2-methyl-, polymer with oxirane, mono(2-propylhcptyl)

Supplemental label elements

Special packaging requirements

Version: /.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

2.3 Other hazards

Substance meets the criteria for No.

Substance meets the criteria for

Other hazards which do not

I SECTION 3: Composition/information on ingredients

Product/ingredient name % Regulation (EC) No. 1272/2008 (CLP]

Occupational exposure limits, if available, are listed in Section 8.

I SECTION 4: First aid measures

Version: 1.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

Potential acute health effects

Eye contact Adverse symptoms may include the following:

Adverse symptoms may include the following:

I SECTION 5: Firefighting measures

5.2 Special hazards arising from the substance or mixture

5.3 Advice for firefighters

I SECTION 6: Accidental release measures

6.1 Personal precautions, protective equipment and emergency procedures

For non-emergency personnel

6.2 Environmental precautions

6.3 Methods and materials for containment and cleaning up

SECTION 7: Handling and storage

Versio11: 1.0 Dme ofissue/Dnte ofrevisio11: 2901.2019 Dme ofprevio11s issue:

73 Specific end use(s)

\ SECTION 8: Exposure controls/personal protection

Occupational exposure limits

No exposure limit value known.

8.2 Exposure controls

Appropriate engineering controls

Individual protection measures

Version: 1.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

TERGAFLOR ML Page: 12120

I SECTION 9: Physical and chemical properties

Melting point/freezing point

Initial boiling point and boiling

Kinematic: 60 mm2/s @23 °C (DIN 51562)

Version: 1.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

voe (2004/42/EC) 0,2% w/w

I SECTION 10: Stability and reactivity

The product is stable.

SECTION 11: Toxicolo ical information

Acute toxicity estimates I Oral

Version: 1.0 Date of issue/Date of revision: 29.01.2019 Date of previous issue:

Conclusion/Summary Not available.

Conclusion/Summary Not available.